Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.84 - $16.79 $2,900 - $6,212
-370 Reduced 2.4%
15,030 $125,000
Q1 2024

May 14, 2024

BUY
$13.2 - $17.76 $203,280 - $273,504
15,400 New
15,400 $273,000
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $389,271 - $501,784
64,663 Added 26.31%
310,398 $2.2 Million
Q2 2023

Aug 11, 2023

BUY
$5.79 - $9.11 $643,651 - $1.01 Million
111,166 Added 82.61%
245,735 $1.85 Million
Q1 2023

May 12, 2023

SELL
$7.36 - $12.72 $122,455 - $211,635
-16,638 Reduced 11.0%
134,569 $1.08 Million
Q4 2022

Feb 10, 2023

BUY
$7.02 - $9.76 $1.06 Million - $1.48 Million
151,207 New
151,207 $1.37 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.